POSTPRANDIAL METABOLISM OF APOB-CONTAINING LIPOPROTEINS APOC3 LOSS-OF-FUNCTION OR GAIN-OF-FUNCTION MUTATIONS

被引:0
|
作者
Boren, Jan [1 ]
机构
[1] Univ Gothenburg, Gothenburg, Sweden
关键词
D O I
10.1016/j.atherosclerosis.2024.118836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Loss-of-Function and Gain-of-Function Consequences of GATA2 Disease Mutations
    Katsumura, Koichi Ricardo
    Liu, Peng
    Mehta, Charu
    Hewitt, Kyle J.
    Soukup, Alexandra
    de Andrade, Isabela J. Fraga
    Ranheim, Erik A.
    Johnson, Kirby D.
    Bresnick, Emery H.
    BLOOD, 2019, 134
  • [12] Prediction of gain-of-function and loss-of-function mutations using In Silico Bioinformatics Tools
    Ghosh, A.
    Navarini, A.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E41 - E41
  • [13] Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease (vol 371, pg 22, 2014)
    Crosby, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 690 - 690
  • [14] LOSS-OF-FUNCTION IN APOC3 AND PROTECTION AGAINST CALCIFIC AORTIC VALVE STENOSIS
    Bourgault, Jerome
    Houessou, Ursula
    Bosse, Yohan
    Mathieu, Patrick
    Theriault, Sebastien
    Arsenault, Benoit
    ATHEROSCLEROSIS, 2024, 395
  • [15] Effects of ApoE on metabolism of ApoB lipoproteins are antagonized by ApoC3: A kinetic study in humans
    Zheng, Chunyu
    Khoo, Christina
    Ikewaki, Katsunori
    Sacks, Frank M.
    CIRCULATION, 2006, 114 (18) : 113 - 113
  • [16] Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders
    Mizuguchi, Takeshi
    Nakashima, Mitsuko
    Kato, Mitsuhiro
    Okamoto, Nobuhiko
    Kurahashi, Hirokazu
    Ekhilevitch, Nina
    Shiina, Masaaki
    Nishimura, Gen
    Shibata, Takashi
    Matsuo, Muneaki
    Ikeda, Tae
    Ogata, Kazuhiro
    Tsuchida, Naomi
    Mitsuhashi, Satomi
    Miyatake, Satoko
    Takata, Atsushi
    Miyake, Noriko
    Hata, Kenichiro
    Kaname, Tadashi
    Matsubara, Yoichi
    Saitsu, Hirotomo
    Matsumoto, Naomichi
    HUMAN MOLECULAR GENETICS, 2018, 27 (08) : 1421 - 1433
  • [17] Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations
    Hopkins, P. N.
    Krempf, M.
    Bruckert, E.
    Luc, G.
    Donahue, S.
    Yang, F.
    Zhang, Y.
    Dicioccio, A. T.
    EUROPEAN HEART JOURNAL, 2018, 39 : 49 - 49
  • [18] JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences
    Nils Ott
    Laura Faletti
    Maximilian Heeg
    Virginia Andreani
    Bodo Grimbacher
    Journal of Clinical Immunology, 2023, 43 : 1326 - 1359
  • [19] JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences
    Ott, Nils
    Faletti, Laura
    Heeg, Maximilian
    Andreani, Virginia
    Grimbacher, Bodo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1326 - 1359
  • [20] Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis The Multi-Ethnic BioImage Study
    Natarajan, Pradeep
    Kohli, Puja
    Baber, Usman
    Nguyen, Khanh-Dung H.
    Sartori, Samantha
    Reilly, Dermot F.
    Mehran, Roxana
    Muntendam, Pieter
    Fuster, Valentin
    Rader, Daniel J.
    Kathiresan, Sekar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (18) : 2053 - 2055